Annexin A5 promotes macrophage activation and contributes to pulmonary fibrosis induced by silica particles

C Luo1, X Ji1, J Fan1

  • 1Department of Occupational Medicine and Environmental Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.

Abstract

Insights

Annexin A5 promotes silica-induced lung fibrosis by activating macrophages through Fas/FasL pathways. Reducing annexin A5 levels reversed fibrosis markers in a mouse model, highlighting its therapeutic potential.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cell Biology

Background:

  • Silica exposure is a known cause of pulmonary fibrosis.
  • The molecular mechanisms driving silica-induced lung fibrosis are not fully understood.

Purpose of the Study:

  • To investigate the role of annexin A5 in silica-induced pulmonary fibrosis.
  • To elucidate the underlying molecular mechanisms involving annexin A5.

Main Methods:

  • Mice were exposed to silica, and annexin A5 levels were measured in serum and lung tissue.
  • Macrophage cell lines (RAW264.7) were exposed to silica to assess annexin A5-dependent changes in fibrosis-related molecules (TGF-β1, IL-1α, FasL).
  • Small interfering RNA (siRNA) was used to knock down annexin A5 and FasL to evaluate their specific roles.

Main Results:

  • Silica exposure induced lung fibrosis in mice and elevated annexin A5 levels.
  • In macrophages, silica exposure increased annexin A5, TGF-β1, IL-1α, and FasL expression.
  • Knockdown of annexin A5 reversed silica-induced changes, while FasL downregulation increased annexin A5.

Conclusions:

  • Annexin A5 plays a significant role in promoting macrophage activation in silica-induced lung fibrosis.
  • The Fas/FasL pathway is implicated in annexin A5-mediated macrophage activation.
  • Annexin A5 represents a potential therapeutic target for pulmonary fibrosis.